Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (171-180 of 320) with videos related to

Pageof 32
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 30, 2021
Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel diseasePaula Sousa, Paula Ministro, Alessandro Armuzzi, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2024
Management of Clostridioides difficile infection: an Italian Delphi consensusMatteo Bassetti, Antonio Cascio, Francesco Giuseppe De Rosa, et al.
Digestive Diseases (Basel, Switzerland)|March 8, 2018
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's DiseaseLucrezia Laterza, Anna Chiara Piscaglia, Laura Maria Minordi, et al.
Advances in Therapy|April 1, 2026
Efficacy and Safety of Ravagalimab in Patients with Moderate-to-Severe Ulcerative Colitis: Data from a Phase 2a TrialLaurent Peyrin-Biroulet, John Paul Seenan, Alessandro Armuzzi, et al.
European Journal of Gastroenterology & Hepatology|January 20, 2022
Assessing aCCess to Investigations in Inflammatory Bowel Disease (ACCID): results from an international surveyNik S Ding, Tanya Lee, Dominik Bettenworth, et al.
Radiology|December 14, 2011
Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activityAntonio De Franco, Alessandra Di Veronica, Alessandro Armuzzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 16, 2019
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Gionata Fiorino, Flavio Caprioli, Marco Daperno, et al.
Biomed Research International|September 25, 2013
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agentsLuisa Guidi, Carla Felice, Annabella Procoli, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2020
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patientsLorenzo Bertani, Domenico Tricò, Daniela Pugliese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2019
Histopathology of inflammatory bowel disease - Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC)Vincenzo Villanacci, Luca Reggiani-Bonetti, Flavio Caprioli, et al.
Pageof 32

Showing results (171-180 of 320) with videos related to

Sort By:
Pageof 32
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 30, 2021
Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel diseasePaula Sousa, Paula Ministro, Alessandro Armuzzi, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 2024
Management of Clostridioides difficile infection: an Italian Delphi consensusMatteo Bassetti, Antonio Cascio, Francesco Giuseppe De Rosa, et al.
Digestive Diseases (Basel, Switzerland)|March 8, 2018
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's DiseaseLucrezia Laterza, Anna Chiara Piscaglia, Laura Maria Minordi, et al.
Advances in Therapy|April 1, 2026
Efficacy and Safety of Ravagalimab in Patients with Moderate-to-Severe Ulcerative Colitis: Data from a Phase 2a TrialLaurent Peyrin-Biroulet, John Paul Seenan, Alessandro Armuzzi, et al.
European Journal of Gastroenterology & Hepatology|January 20, 2022
Assessing aCCess to Investigations in Inflammatory Bowel Disease (ACCID): results from an international surveyNik S Ding, Tanya Lee, Dominik Bettenworth, et al.
Radiology|December 14, 2011
Ileal Crohn disease: mural microvascularity quantified with contrast-enhanced US correlates with disease activityAntonio De Franco, Alessandra Di Veronica, Alessandro Armuzzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 16, 2019
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Gionata Fiorino, Flavio Caprioli, Marco Daperno, et al.
Biomed Research International|September 25, 2013
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agentsLuisa Guidi, Carla Felice, Annabella Procoli, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2020
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patientsLorenzo Bertani, Domenico Tricò, Daniela Pugliese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2019
Histopathology of inflammatory bowel disease - Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC)Vincenzo Villanacci, Luca Reggiani-Bonetti, Flavio Caprioli, et al.
Pageof 32